Role of FGF23 in Pediatric Hypercalciuria

Table 1

Demographic data of hypercalciuric (H) patients, controls, and Pre-Treated and Treated patients with hypercalciuria.

Parameters	H patients	Controls		Pre-Treated	Treated
Age (yr)	16.3 (6.3–24.8)	16.7 (2.0–24.7)	0.655	16.9 (7.6–24.8)	15.7 (6.3–23.7)	0.33
Male (/%)	35/60.5	20/66.5	0.561	14/58.5	21/62	0.79
BMI Z-score			0.688			0.49
White skin color (/%)	38/65.5	17/57		13/54	23/67.5
Urolithiasis (Y/%)	44/76	0/0	-	18/75	26/76.5	0.89

Data are median (25th and 75th percentiles), mean ± SD, or percentage (number); Y: yes; tests: two-tailed t-test, Wilcoxon rank sum test (two-sided), or Kruskal-Wallis test, ANOVA.